R4 Ballot #1 (Mixed Normative/Trial use)
FoundationThis page is part of the FHIR Specification (v3.3.0: R4 Ballot 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B R4
| Modeling and Methodology Work Group | Maturity Level: N/A | Ballot Status: Informative |
StructureDefinition for MarketingStatus
{
"resourceType": "StructureDefinition",
"id": "MarketingStatus",
"meta": {
"lastUpdated": "2018-04-03T12:05:46.262+10:00"
},
"text": {
"status": "generated",
"div": "<div>!-- Snipped for Brevity --></div>"
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/structuredefinition-ballot-status",
"valueString": "Draft"
}
],
"url": "http://hl7.org/fhir/StructureDefinition/MarketingStatus",
"name": "MarketingStatus",
"status": "draft",
"date": "2018-04-03T12:05:46+10:00",
"publisher": "HL7 FHIR Standard",
"contact": [
{
"telecom": [
{
"system": "url",
"value": "http://hl7.org/fhir"
}
]
}
],
"description": "Base StructureDefinition for MarketingStatus Type: The marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available.",
"fhirVersion": "3.3.0",
"mapping": [
{
"identity": "rim",
"uri": "http://hl7.org/v3",
"name": "RIM Mapping"
}
],
"kind": "complex-type",
"abstract": false,
"type": "MarketingStatus",
"baseDefinition": "http://hl7.org/fhir/StructureDefinition/BackboneElement",
"derivation": "specialization",
"snapshot": {
"element": [
{
"id": "MarketingStatus",
"path": "MarketingStatus",
"short": "The marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available",
"definition": "The marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available.",
"min": 0,
"max": "*",
"base": {
"path": "MarketingStatus",
"min": 0,
"max": "*"
},
"isModifier": false,
"mapping": [
{
"identity": "rim",
"map": "n/a"
}
]
},
{
"id": "MarketingStatus.id",
"path": "MarketingStatus.id",
"representation": [
"xmlAttr"
],
"short": "xml:id (or equivalent in JSON)",
"definition": "Unique id for the element within a resource (for internal references). This may be any string value that does not contain spaces.",
"min": 0,
"max": "1",
"base": {
"path": "Element.id",
"min": 0,
"max": "1"
},
"type": [
{
"code": "string"
}
],
"isModifier": false,
"isSummary": false,
"mapping": [
{
"identity": "rim",
"map": "n/a"
}
]
},
{
"id": "MarketingStatus.extension",
"path": "MarketingStatus.extension",
"slicing": {
"discriminator": [
{
"type": "value",
"path": "url"
}
],
"description": "Extensions are always sliced by (at least) url",
"rules": "open"
},
"short": "Additional content defined by implementations",
"definition": "May be used to represent additional information that is not part of the basic definition of the element. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension.",
"comment": "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
"alias": [
"extensions",
"user content"
],
"min": 0,
"max": "*",
"base": {
"path": "Element.extension",
"min": 0,
"max": "*"
},
"type": [
{
"code": "Extension"
}
],
"isModifier": false,
"isSummary": false,
"mapping": [
{
"identity": "rim",
"map": "n/a"
}
]
},
{
"id": "MarketingStatus.modifierExtension",
"path": "MarketingStatus.modifierExtension",
"short": "Extensions that cannot be ignored",
"definition": "May be used to represent additional information that is not part of the basic definition of the element and that modifies the understanding of the element in which it is contained. Usually modifier elements provide negation or qualification. To make the use of extensions safe and manageable, there is a strict set of governance applied to the definition and use of extensions. Though any implementer can define an extension, there is a set of requirements that SHALL be met as part of the definition of the extension. Applications processing a resource are required to check for modifier extensions.",
"comment": "There can be no stigma associated with the use of extensions by any application, project, or standard - regardless of the institution or jurisdiction that uses or defines the extensions. The use of extensions is what allows the FHIR specification to retain a core level of simplicity for everyone.",
"alias": [
"extensions",
"user content",
"modifiers"
],
"min": 0,
"max": "*",
"base": {
"path": "BackboneElement.modifierExtension",
"min": 0,
"max": "*"
},
"type": [
{
"code": "Extension"
}
],
"isModifier": true,
"isModifierReason": "modifierExtension is reserved for use where modifier extensions must be used",
"isSummary": true,
"mapping": [
{
"identity": "rim",
"map": "N/A"
}
]
},
{
"id": "MarketingStatus.country",
"path": "MarketingStatus.country",
"short": "The country in which the marketing authorisation has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements",
"definition": "The country in which the marketing authorisation has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements.",
"min": 1,
"max": "1",
"base": {
"path": "MarketingStatus.country",
"min": 1,
"max": "1"
},
"type": [
{
"code": "CodeableConcept"
}
],
"isModifier": false,
"isSummary": true
},
{
"id": "MarketingStatus.jurisdiction",
"path": "MarketingStatus.jurisdiction",
"short": "Where a Medicines Regulatory Agency has granted a marketing authorisation for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified",
"definition": "Where a Medicines Regulatory Agency has granted a marketing authorisation for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified.",
"min": 0,
"max": "1",
"base": {
"path": "MarketingStatus.jurisdiction",
"min": 0,
"max": "1"
},
"type": [
{
"code": "CodeableConcept"
}
],
"isModifier": false,
"isSummary": true
},
{
"id": "MarketingStatus.status",
"path": "MarketingStatus.status",
"short": "This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples",
"definition": "This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples.",
"min": 1,
"max": "1",
"base": {
"path": "MarketingStatus.status",
"min": 1,
"max": "1"
},
"type": [
{
"code": "CodeableConcept"
}
],
"isModifier": false,
"isSummary": true
},
{
"id": "MarketingStatus.dateRange",
"path": "MarketingStatus.dateRange",
"short": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain",
"definition": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain.",
"min": 1,
"max": "1",
"base": {
"path": "MarketingStatus.dateRange",
"min": 1,
"max": "1"
},
"type": [
{
"code": "Period"
}
],
"isModifier": false,
"isSummary": true
},
{
"id": "MarketingStatus.restoreDate",
"path": "MarketingStatus.restoreDate",
"short": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain",
"definition": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain.",
"min": 0,
"max": "1",
"base": {
"path": "MarketingStatus.restoreDate",
"min": 0,
"max": "1"
},
"type": [
{
"code": "dateTime"
}
],
"isModifier": false,
"isSummary": true
}
]
},
"differential": {
"element": [
{
"id": "MarketingStatus",
"path": "MarketingStatus",
"short": "The marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available",
"definition": "The marketing status describes the date when a medicinal product is actually put on the market or the date as of which it is no longer available.",
"min": 0,
"max": "*"
},
{
"id": "MarketingStatus.country",
"path": "MarketingStatus.country",
"short": "The country in which the marketing authorisation has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements",
"definition": "The country in which the marketing authorisation has been granted shall be specified It should be specified using the ISO 3166 ‑ 1 alpha-2 code elements.",
"min": 1,
"max": "1",
"type": [
{
"code": "CodeableConcept"
}
],
"isSummary": true
},
{
"id": "MarketingStatus.jurisdiction",
"path": "MarketingStatus.jurisdiction",
"short": "Where a Medicines Regulatory Agency has granted a marketing authorisation for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified",
"definition": "Where a Medicines Regulatory Agency has granted a marketing authorisation for which specific provisions within a jurisdiction apply, the jurisdiction can be specified using an appropriate controlled terminology The controlled term and the controlled term identifier shall be specified.",
"min": 0,
"max": "1",
"type": [
{
"code": "CodeableConcept"
}
],
"isSummary": true
},
{
"id": "MarketingStatus.status",
"path": "MarketingStatus.status",
"short": "This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples",
"definition": "This attribute provides information on the status of the marketing of the medicinal product See ISO/TS 20443 for more information and examples.",
"min": 1,
"max": "1",
"type": [
{
"code": "CodeableConcept"
}
],
"isSummary": true
},
{
"id": "MarketingStatus.dateRange",
"path": "MarketingStatus.dateRange",
"short": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain",
"definition": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain.",
"min": 1,
"max": "1",
"type": [
{
"code": "Period"
}
],
"isSummary": true
},
{
"id": "MarketingStatus.restoreDate",
"path": "MarketingStatus.restoreDate",
"short": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain",
"definition": "The date when the Medicinal Product is placed on the market by the Marketing Authorisation Holder (or where applicable, the manufacturer/distributor) in a country and/or jurisdiction shall be provided A complete date consisting of day, month and year shall be specified using the ISO 8601 date format NOTE “Placed on the market” refers to the release of the Medicinal Product into the distribution chain.",
"min": 0,
"max": "1",
"type": [
{
"code": "dateTime"
}
],
"isSummary": true
}
]
}
}
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.
®© HL7.org 2011+. FHIR Mixed Nomative/Trial Use Ballot (v3.3.0-13671) generated on Tue, Apr 3, 2018 12:13+1000. QA Page
Links: Search |
Version History |
Table of Contents |
Credits |
Compare to DSTU3 |
|
Propose a change